Platelet is a major contributor to circulating levels of Dickkopf‐1: clinical implications in patients with multiple myeloma

This publication has 10 references indexed in Scilit:

• The role of Dickkopf-1 in bone development, homeostasis, and disease
  Blood, 2009
• Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
  Blood, 2008
• Increased Dickkopf-1 expression in breast cancer bone metastases
  British Journal of Cancer, 2007
• Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome
  Blood, 2007
• Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
  Journal of Clinical Investigation, 2004
• The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma
  New England Journal of Medicine, 2003
• Acid citrate dextrose (acd) formula a as a new anticoagulant in the measurement of in vitro platelet aggregation
  Journal of Clinical Laboratory Analysis, 1995
• Localization of platelet osteonectin at the internal face of the alpha- granule membranes in platelets and megakaryocytes
  Blood, 1992
• Platelets contribute to circulating levels of bone sialoprotein in human
  Journal of Bone and Mineral Research, 1992
• Human platelets contain and secrete osteonectin, a major protein of mineralized bone.
  Proceedings of the National Academy of Sciences, 1986